4
Changes in Ownership
OCULAR THERAPEUTIX, INC Filed Acc 0001104659-26-067478
Chief Strategy Officer sold 1,858 shares at $8.20 ($15,236)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Nayak Sanjay · Chief Strategy Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-26 | Sale : show line 1 in the form 10b5-1 | −1,858 | $8.20 | $15,236 | 328,795 | D |
| Open-market sales · 1,858 sh · avg $8.20 · $15,236 | ||||||
Loading xslF345X06/tm2615856-1_4seq1.xml…